Related Articles
Prognostic value of the neutrophil‑lymphocyte, platelet‑lymphocyte and monocyte‑lymphocyte ratio in breast cancer patients
Platelet‑to‑lymphocyte and neutrophil‑to‑lymphocyte ratios are associated with the efficacy of immunotherapy in stage III/IV non‑small cell lung cancer
Absolute lymphocyte count and C‑reactive protein‑albumin ratio can predict prognosis and adverse events in patients with recurrent esophageal cancer treated with nivolumab therapy
Efficacy of circulating microRNA‑130b and blood routine parameters in the early diagnosis of gastric cancer
Neutrophil‑to‑lymphocyte and platelet‑to‑lymphocyte ratios may aid in identifying patients with non‑small cell lung cancer and predicting Tumor‑Node‑Metastasis stages